These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6322391)

  • 1. Primary cytomegalovirus infection following cardiac transplantation in a murine model.
    Rubin RH; Wilson EJ; Barrett LV; Medearis DN
    Transplantation; 1984 Mar; 37(3):306-10. PubMed ID: 6322391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The source of murine cytomegalovirus in mice receiving kidney allografts.
    Klotman ME; Starnes D; Hamilton JD
    J Infect Dis; 1985 Dec; 152(6):1192-6. PubMed ID: 2999256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of murine cardiac allograft acceptance by latent cytomegalovirus.
    Cook CH; Bickerstaff AA; Wang JJ; Zimmerman PD; Forster MR; Nadasdy T; Colvin RB; Hadley GA; Orosz CG
    Am J Transplant; 2009 Jan; 9(1):42-53. PubMed ID: 18976295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine cytomegalovirus gene amplification and culture after submaxillary salivary gland biopsy.
    Schmader KE; Rahija RJ; Porter KR; Hamilton JD
    Lab Anim Sci; 1991 Oct; 41(5):396-400. PubMed ID: 1666135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic cell stimulation enhances cytomegalovirus replication in the early period of primary infection in an experimental rat model.
    Tamura K; Oka T; Ohsawa K; Koji T; Watanabe Y; Katamine S; Sato H; Ayabe H
    J Heart Lung Transplant; 2003 Apr; 22(4):452-9. PubMed ID: 12681423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus latency promotes cardiac lymphoid neogenesis and accelerated allograft rejection in CMV naïve recipients.
    Orloff SL; Hwee YK; Kreklywich C; Andoh TF; Hart E; Smith PA; Messaoudi I; Streblow DN
    Am J Transplant; 2011 Jan; 11(1):45-55. PubMed ID: 21199347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model for reactivation of CMV from latency.
    Hummel M; Abecassis MM
    J Clin Virol; 2002 Aug; 25 Suppl 2():S123-36. PubMed ID: 12361763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infections due to herpesviruses in cardiac transplant recipients: role of the donor heart and immunosuppressive therapy.
    Preiksaitis JK; Rosno S; Grumet C; Merigan TC
    J Infect Dis; 1983 Jun; 147(6):974-81. PubMed ID: 6304206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of latent cytomegalovirus in a murine kidney tissue transplantation model.
    Hamilton JD; Seaworth BJ
    Transplantation; 1985 Mar; 39(3):290-6. PubMed ID: 2983462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cell transplantation with latently infected donors does not transmit virus to immunocompromised recipients in the murine model of cytomegalovirus infection.
    Seckert CK; Renzaho A; Reddehase MJ; Grzimek NK
    Med Microbiol Immunol; 2008 Jun; 197(2):251-9. PubMed ID: 18365252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myopericarditis and enhanced dystrophic cardiac calcification in murine cytomegalovirus infection.
    Gang DL; Barrett LV; Wilson EJ; Rubin RH; Medearis DN
    Am J Pathol; 1986 Aug; 124(2):207-15. PubMed ID: 3017116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of latent murine cytomegalovirus infection: cocultivation, cell transfer, and the effect of immunosuppression.
    Mayo D; Armstrong JA; Ho M
    J Infect Dis; 1978 Dec; 138(6):890-6. PubMed ID: 216752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection.
    Balthesen M; Dreher L; Lucin P; Reddehase MJ
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2329-36. PubMed ID: 8077931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of mouse cytomegalovirus infection during host-versus-graft reaction.
    Wu BC; Dowling JN; Armstrong JA; Ho M
    Science; 1975 Oct; 190(4209):56-8. PubMed ID: 170676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus infections in heart and heart-lung transplant recipients.
    Wreghitt T
    J Antimicrob Chemother; 1989 Jun; 23 Suppl E():49-60. PubMed ID: 2550412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus (CMV) in the compromised host(s).
    Betts RF; Hanshaw JB
    Annu Rev Med; 1977; 28():103-10. PubMed ID: 193429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive transfer of cytomegalovirus by cardiac and renal organ transplants in a rat model.
    Bruning JH; Bruggeman CA; van Boven CP; van Breda Vriesman PJ
    Transplantation; 1986 Jun; 41(6):695-8. PubMed ID: 3012832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Importance of screening for antibodies to cytomegalovirus in organ transplantation].
    Milbradt H; Flik J; Stangel W; Heigel R
    Beitr Infusionsther; 1990; 26():33-6. PubMed ID: 1703866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivation of rat cytomegalovirus in lung allografts: an experimental and immunohistochemical study in rats.
    Yagyu K; Steinhoff G; Duijvestijn AM; Bruggeman CA; Matsumoto H; van Breda Vriesman PJ
    J Heart Lung Transplant; 1992; 11(6):1031-40. PubMed ID: 1333797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of donor factors other than serologic status on transmission of cytomegalovirus to transplant recipients.
    Chou SW; Norman DJ
    Transplantation; 1988 Jul; 46(1):89-93. PubMed ID: 2839917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.